Stable reexpression of Smad4 in colorectal and pancreatic carcinoma cells at physiological levels was adequate to suppress tumour growth in vivo, but did not restore TGF-β responsiveness [14,15]. The gene discussed is TGFB1; the disease is exocrine pancreatic carcinoma.